ResearcherRenmin Hospital of Wuhan UniversityNo recent work listed
Mengyao Ji
Matched on ORCID iD 0000-0003-2469-0045; OpenAlex author ID A5024680462.
Their work
- Papers
- 3 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Collaborators
- 4
2012: 1 paper · 2013: none · 2014: 1 paper · 2015: 1 paper
Papers 3
- EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway. First author DOI 10.3892/etm.2015.2684↗
- EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2. First author DOI 10.3892/etm.2014.1831↗
- The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells. First author DOI 10.1007/s10735-012-9424-0↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Xiulan Peng · 3 shared papers, 2012–2015
- Paper EBP50 inhibits pancreatic cancer cell growth and invasion by targeting the β-catenin/E-cadherin pathway. DOI 10.3892/etm.2015.2684↗
- Paper EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2. DOI 10.3892/etm.2014.1831↗
- Paper The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated… DOI 10.1007/s10735-012-9424-0↗
- Weiguo Dong · 2 shared papers, 2014–2015
- Lei Yuan · 1 shared paper, 2015
- Weiguo Dong · 1 shared paper, 2012
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.